Deep knowledge on 
 small-molecule drugs and 
 the 110,000 global patents 
 covering them 

Free Patent Expiration Alerts


Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Cisatracurium besylate - Generic Drug Details

« Back to Dashboard
Cisatracurium besylate is the generic ingredient in four branded drugs marketed by Abbvie, Sandoz Inc, and Fresenius Kabi Usa, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cisatracurium besylate. Three suppliers are listed for this compound.

Summary for Generic Name: cisatracurium besylate

Tradenames:4
Patents:0
Applicants:3
NDAs:5
Drug Master File Entries: see list9
Suppliers / Packaging: see list3

Pharmacology for Ingredient: cisatracurium besylate

Clinical Trials for: cisatracurium besylate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION200154-002Feb 3, 2012RXNo<disabled><disabled>
Fresenius Kabi Usa
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION203182-001Feb 26, 2015RXNo<disabled><disabled>
Abbvie
NIMBEX PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION020551-003Dec 15, 1995RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cisatracurium besylate

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
NIMBEX PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION020551-003Dec 15, 19955,453,510<disabled>
Abbvie
NIMBEX
cisatracurium besylate
INJECTABLE;INJECTION020551-001Dec 15, 19954,179,507<disabled>
Abbvie
NIMBEX PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION020551-002Dec 15, 19954,179,507<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Connect with Social Media:

`abc